July 18, 2024

Point-of-Care Testing Market Size Analysis 2022 To 2030

The global point-of-care testing market size accounted for US$ 40.6 Bn in 2021 and is projected to reach around USD 103.2 Bn by 2030, growing at a CAGR of 10.92% from 2022 to 2030.

Point-of-Care Testing Market Key Takeaways:

  • North America was accounted highest revenue share more than 46% in 2021.
  • Asia Pacific POCT market is registering at a CAGR of 9.8% from 2022 to 2030.
  • By product, glucose monitoring products segment has captured highest revenue share 27% in 2021.
  • By platform, lateral flow assays segment has accounted 36% revenue share in 2021.
  • By mode of purchase, OTC testing products segment has held 59% revenue share in 2021.
  • The glucose monitoring segment was valued at USD 8.91 billion in in 2021.
  • The biosensors segment is growing a CAGR of 9.2% during the frorecast period.
  • The pregnancy and fertility testing products segment is expected to reach at a 8.1% of CAGR from 2022 to 2030.
  • The diagnostic centers segment is growing at a CAGR of 7.8% over the forecast period.
Point-of-Care Testing Market Size 2022 To 2030

 

Report Summary

The global point-of-care testing market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the point-of-care testing market across the globe.

A comprehensive estimate on the point-of-care testing market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of point-of-care testing during the forecast period. Price point comparison by region with global average price is also considered in the study.

Point-of-Care Testing Market Scope

Report CoverageDetails
Market Size in 2022USD 45.03 Billion
Market Size by 2030USD 103.2 Billion
Growth Rate from 2022 to 2030CAGR of 10.92%
Base Year2021
Forecast Period2022 to 2030
Segments CoveredProduct Type, Platform, Mode of Purchase, Testing Type, End-User, and Geography

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized point-of-care testing market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Butadiene Market Size Analysis 2022 To 2030

Point-of-Care Testing Market Players

The report includes the profiles of key point-of-care testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area are Sinocare Inc, Hoffmann La Roche Ltd, Siemens AG, Abott Laboratories, bioMrieux SA, Becton Dickinson and Company, Danaher Coraporation, Nova Biomedical, Sysmex corporation, Johnson and Johnson, Biosensor Inc, Fluxergy, Precision, Ascensia Diabetes Care Holding AG, LifeScan IP Holdings, LLC, Mankind pharma, OraSure Technologies, inc, A. Menarini Diagnostics s.r.l, ACON Laboratories, Trinity Biotech plc

Market Segmentation

By Product Type

  • Covid -19 testing kits
  • Glucose monitoring products
    • Meters
    • Strips
    • Lancets and Lancing devices
  • Cardiometabolic Monitoring Products
    • Cardiac maker testing products
    • Blood Gas / Electrolyte testing products
    • HbA1c testing products
  • Infectious disease testing products
    • Influenza testing products
    • HIV testing products
    • Hepatitis testing products
    • Sexually Transmitted Diseases testing products
    • Healthcare – associated Infection testing products
    • Respiratory infection testing products
    • Tropical disease testing products
    • others
  • Coagulation monitoring products
    • PT / INR testing
    • ACT / APTT
  • Pregnancy and fertility testing products
  • Pregnancy testing products
  • Fertility testing products
  • Cancer marker testing products
  • Urinanalysis testing products
  • Cholestrol testing products
  • Hematology testing products
  • Drugs-of-abuse testing products
  • Fecal Occult testing products
  • Others

By Platform

By Mode of Purchase

  • OTC products
  • Prescribed based products

By Testing Type

  • Immunoassays
  • Cell-Based Assays
  • Nucleic Acid Amplification Testing
  • Clinical Chemistry Assays
  • Hematology

By End-User

  • Clinical laboratories
  • Ambulatory care facilities and physician offices
  • Pharmacies, retail clinics & E-comm platforms
  • Hospitals, Critical care centres, Urgent care centres
  • Home care & self-testing
  • Others

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Point-of-Care Testing (POCT) Market 

5.1. COVID-19 Landscape: Point-of-Care Testing (POCT) Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Point-of-Care Testing (POCT) Market, By Product Type

8.1. Point-of-Care Testing (POCT) Market, by Product Type, 2022-2030

8.1.1. Covid -19 testing kits

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Glucose monitoring products

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Cardiometabolic Monitoring Products

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Infectious disease testing products

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Coagulation monitoring products

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Pregnancy and fertility testing products

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Pregnancy testing products

8.1.7.1. Market Revenue and Forecast (2017-2030)

8.1.8. Fertility testing products

8.1.8.1. Market Revenue and Forecast (2017-2030)

8.1.9. Cancer marker testing products

8.1.9.1. Market Revenue and Forecast (2017-2030)

8.1.10. Urinanalysis testing products

8.1.10.1. Market Revenue and Forecast (2017-2030)

8.1.11. Cholestrol testing products

8.1.11.1. Market Revenue and Forecast (2017-2030)

8.1.12. Hematology testing products

8.1.12.1. Market Revenue and Forecast (2017-2030)

8.1.13. Drugs-of-abuse testing products

8.1.13.1. Market Revenue and Forecast (2017-2030)

8.1.14. Fecal Occult testing products

8.1.14.1. Market Revenue and Forecast (2017-2030)

8.1.15. Others

8.1.15.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Point-of-Care Testing (POCT) Market, By Platform

9.1. Point-of-Care Testing (POCT) Market, by Platform, 2022-2030

9.1.1. Lateral Flow Assays

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Dipsticks

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Microfluids

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Molecular Diagnostics

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Immunoassays

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Point-of-Care Testing (POCT) Market, By Mode of Purchase 

10.1. Point-of-Care Testing (POCT) Market, by Mode of Purchase, 2022-2030

10.1.1. OTC products

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Prescribed based products

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Point-of-Care Testing (POCT) Market, By Testing Type

11.1. Point-of-Care Testing (POCT) Market, by Testing Type, 2022-2030

11.1.1. Immunoassays

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Cell-Based Assays

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Nucleic Acid Amplification Testing

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Clinical Chemistry Assays

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Hematology

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Point-of-Care Testing (POCT) Market, By End-User

12.1. Point-of-Care Testing (POCT) Market, by End-User, 2022-2030

12.1.1. Clinical laboratories

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Ambulatory care facilities and physician offices

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Pharmacies, retail clinics & E-comm platforms

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Hospitals, Critical care centres, Urgent care centres

12.1.4.1. Market Revenue and Forecast (2017-2030)

12.1.5. Home care & self-testing

12.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Point-of-Care Testing (POCT) Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.1.2. Market Revenue and Forecast, by Platform (2017-2030)

13.1.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.1.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.1.5. Market Revenue and Forecast, by End-User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Platform (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.1.6.5. Market Revenue and Forecast, by End-User (2017-2030)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Platform (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.1.7.5. Market Revenue and Forecast, by End-User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.2. Market Revenue and Forecast, by Platform (2017-2030)

13.2.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.2.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.2.5. Market Revenue and Forecast, by End-User (2017-2030)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Platform (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.2.7. Market Revenue and Forecast, by Testing Type (2017-2030)

13.2.8. Market Revenue and Forecast, by End-User (2017-2030)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Platform (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.2.10. Market Revenue and Forecast, by Testing Type (2017-2030)

13.2.11. Market Revenue and Forecast, by End-User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Platform (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.2.13. Market Revenue and Forecast, by End-User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Platform (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.2.15. Market Revenue and Forecast, by End-User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.2. Market Revenue and Forecast, by Platform (2017-2030)

13.3.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.3.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.3.5. Market Revenue and Forecast, by End-User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Platform (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.3.7. Market Revenue and Forecast, by End-User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Platform (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.3.9. Market Revenue and Forecast, by End-User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Platform (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End-User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Platform (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.2. Market Revenue and Forecast, by Platform (2017-2030)

13.4.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.4.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.4.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Platform (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.4.7. Market Revenue and Forecast, by End-User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Platform (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.4.9. Market Revenue and Forecast, by End-User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Platform (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Platform (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End-User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.5.2. Market Revenue and Forecast, by Platform (2017-2030)

13.5.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.5.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.5.5. Market Revenue and Forecast, by End-User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Platform (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.5.7. Market Revenue and Forecast, by End-User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Platform (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End-User (2017-2030)

Chapter 14. Company Profiles

14.1. Sinocare Inc

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Hoffmann La Roche Ltd

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Siemens AG

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Abott Laboratories

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. bioMrieux SA

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Becton Dickinson and Company

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Danaher Coraporation

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Nova Biomedical

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9.Sysmex corporation

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Johnson and Johnson

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2270

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →